A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy

Lancet Oncol. 2011 Mar;12(3):211-4. doi: 10.1016/S1470-2045(10)70275-8.

Authors

Matthew D Galsky¹, Noah M Hahn, Jonathan Rosenberg, Guru Sonpavde, Thomas Hutson, William K Oh, Robert Dreicer, Nicholas Vogelzang, Cora Sternberg, Dean F Bajorin, Joaquim Bellmunt

Affiliation

¹ Tisch Cancer Institute, Mount Sinai School of Medicine, New York NY, USA. matthew.galsky@mssm.edu

PMID: 21376284
DOI: 10.1016/S1470-2045(10)70275-8

No abstract available

MeSH terms

Aged
Antineoplastic Agents / therapeutic use
Cisplatin / therapeutic use
Consensus
Humans
Middle Aged
Urologic Neoplasms / drug therapy*
Urologic Neoplasms / pathology
Urologic Neoplasms / secondary
Urothelium / pathology

Substances

Antineoplastic Agents
Cisplatin